Recently, the first version of the drug catalog for people infected with COVID-19 was released, in which diclofenac sodium enteric coated sustained-release capsules were included. In order to meet the increasing market demand in the near future, Dequan Pharmaceutical (Jiangsu) Co., Ltd., located in Lujia Town, is busy in its production and packaging workshops. It tries its best to adjust the production line, increase the production capacity, and increase the horsepower to produce diclofenac sodium enteric-coated capsules.

Yongxin Pharmaceuticals (1716) today announced that it passed the FDA factory inspection again with zero 483 missing. After the completion of this factory inspection, the company will continue to sell products in the United States and accept the entrustment of IMPAX and the United States Pharmaceutical Factory. The new products can also be sold in the United States market. It is expected that the company's export sales performance will also have significant growth opportunities.

On April 20, a strong earthquake of magnitude 7.0 occurred in Lushan County, Ya'an City, Sichuan Province, causing heavy losses to the lives and property of the people in the disaster area. The company donated 1 million yuan of medicine to the disaster area at the first time, and prayed for all safety!

As of June 4, 2008, medical enterprises in Suzhou had donated a total of 33.0161 million yuan to the disaster area, including 23.6502 million yuan of medical devices and 9.3659 million yuan of donations. There are 12 enterprises that have donated more than 1 million yuan. Yongxin Pharmaceutical Industry (Kunshan) Co., Ltd. donated 3.908 million yuan of drugs and employees voluntarily donated 34000 yuan.

Aluminium-magnesium dimethicone chewing tablets are recognized as high-tech products of Jiangsu Province

Yongxin Kunshan has won the title of a foreign-funded research and development institution in Jiangsu Province